UPDATE: KeyBanc On IQVIA Price Target Raise: Firm Updates Targeted Annual Revenue Growth From 6-9% To 8-11% With Opportunity To Expand Into Lab Services For Precision Medicines; Highlights Recent Acquisition Of Biomarker Detection Business In Europe